Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1558 of 6351
-
Zapping breathing muscles may speed ventilator weaning
Symptom relief CompletedThis trial evaluates whether transcutaneous diaphragmatic/phrenic nerve stimulation (TEDS), abdominal functional electrical stimulation (abFES), or their combination, accelerates and improves the quality of weaning from prolonged invasive mechanical ventilation (IMV), compared wi…
Sponsor: Capital Medical University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New drug targets tough KRAS cancers in early trial
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety, pharmacokinetics, and anti-tumor activity of TLN-372 as a single agent and in combination with other anti-tumor agents, in patients with advanced KRAS mutant solid tumors
Phase 1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New rotating catheter aims to unclog leg arteries without major surgery
Disease control Recruiting nowThe XTRACT Registry is a prospective, single arm multicenter study on the use of on the Rotarex(TM) Rotational Excisional Atherectomy System.
Sponsor: C. R. Bard • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New eye implant could ease glaucoma pressure
Disease control Recruiting nowThis is a prospective, multi-center, international, cohort expansion study. Part 1 will be conducted in subjects with open angle glaucoma to identify the best insertion tool for MINIject S+. In Part 1, three different investigational insertion tools will be used to place MINIject…
Sponsor: iSTAR Medical • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for lymphoma patients: glofitamab studied in Real-World setting
Disease control Recruiting nowThis study will investigate how well glofitamab-based therapy works and how safe it is in Chinese adult participants with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis Phase I clinical trial evaluates the safety, tolerability, and optimal dosing of Zanzalintinib in combination with Pembrolizumab and Cetuximab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). The study aims to establish t…
Phase 1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New drug shows promise for rare bone and soft tissue cancers
Disease control Recruiting nowThis is a single-center, open-label phase II study of QL1706 for the treatment of advanced bone and soft tissue sarcomas.The study includes screening period, treatment period and follow-up period. Subjects will receive QL1706 5mg/kg iv every 3 weeks until disease progression or i…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for rare stomach cancer: drug cocktail targets tough cases
Disease control Recruiting nowThis study is a single-arm study aimed at evaluating the efficacy and safety of Iparomlimab and Tuvonralimab Injection combined with apatinib and irinotecan hydrochloride in the treatment of advanced alpha-fetoprotein gastric cancer (AFPGC) that progresses from first-line PD-1 co…
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a stress hormone be behind the hidden danger of low blood sugar?
Knowledge-focused CompletedThe goal of this trial is to study the effect that adrenaline has on the immune reaction seen during a low blood sugar. People with type 1 diabetes do not produce their own insulin. The cells in the pancreas that produce insulin are destroyed. People with type 1 diabetes require …
Sponsor: Radboud University Medical Center • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New drug trial aims to tame chronic lung infections
Disease control Recruiting nowThis is a phase III, single-arm, open-label, multicenter study to assess the safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.
Phase 3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental cell therapy targets tough blood cancers and anemia
Disease control Recruiting nowThe goal of this clinical study is to evaluate the safety and efficacy of GT801 injection in adult patients with relapsed/refractory CD19-positive B-cell hematologic malignancies and autoimmune hemolytic anemia. Interim analysis conducted when 2 patients complete primary endpoint…
Early phase 1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug tulisokibart aims to ease back pain and stiffness in ankylosing spondylitis
Disease control Recruiting nowResearchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and inflammation (swelling) in the spine and joints in the pelvis (hip bone). Radiographic means the damage it causes can be s…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 10, 2026 11:00 UTC
-
New pill could clear psoriasis skin in weeks
Disease control Not yet recruitingThe purpose of this study is to assess the efficacy and safety of HSK44459 administered orally for moderate to severe plaque psoriasis in adults.
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 12:57 UTC
-
Could immune cells tame advanced bladder cancer? early trial aims to find out
Disease control Not yet recruitingWe plan to enroll 20-29 patients with advanced bladder cancer to undergo T-cell therapy. Each treatment cycle consists of three T-cell infusions, with two cycles planned per patient. Each cycle will include imaging studies, laboratory tests, and vital sign monitoring to evaluate …
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Back pain breakthrough? own cells injected into damaged discs
Disease control Recruiting nowThis is an open-label, single-center Phase I/II clinical trial investigating the safety and efficacy of autologous nucleus pulposus cells (aNPC) in patients with disc degeneration. Eligible participants are those assessed by the principal investigator to have disc herniation suit…
Phase 1/2 • Sponsor: ASTEROGENE Biomedical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Could a tiny brain zapper ease gulf war Veterans' pain?
Symptom relief Recruiting nowThe main goal of the proposed study is to critically evaluate a nonpharmacological and readily available therapy, cranial electrical stimulation (CES) using Alpha-Stim™, and to discover the brain function mechanisms underlying Gulf War Illness-related Headache and Pain (GWI-HAP) …
Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Experimental combo targets stomach cancer fluid after other treatments fail
Disease control Not yet recruitingThis study is a prospective, non-randomized, dual-cohort Phase II clinical trial designed to explore the efficacy and safety of radiotherapy combined with intraperitoneal injection of Recombinant Mutant Human Tumor Necrosis Factor (rmhTNF-NC) and tislelizumab in the treatment of …
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for stubborn nerve disorder: drug combo shows promise
Disease control OngoingThis multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of Telitacicept in patients with refractory chronic inflammatory demyelinating polyneuropathy (CIDP). Eligible patients will be randomly assigned to receive either conventional therapy alone o…
Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug livmarli tracked for Long-Term safety in kids with rare liver disorders
Disease control Recruiting nowIn patients with Alagille syndrome (ALGS), the key objectives are to evaluate the tolerability, long-term safety (including possible liver toxicity) and long-term efficacy of Livmarli treatment. In patients with Progressive Familial Intrahepatic Cholestasis (PFIC), the key objec…
Phase 4 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Dental checkups every 3 months may save cancer Survivors' teeth and smiles
Disease control Recruiting nowThe goal of this clinical trial is to learn if an oral care programme, designed as a multicentre two-armed randomised controlled trial (RCT), can prevent or mitigate late oral sequalae following completion of head and neck cancer (HNC) treatment, and assessing its impact on healt…
Sponsor: Uppsala University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC